Table 5 Physician’s assessments of efficacy of moxifloxacin (efficacy population)
Parameter | Total | Very good / good | Sufficient | Insufficient |
|---|---|---|---|---|
n | n (%) | n (%) | n (%) | |
Gender | ||||
Male | 1441 | 1405 (97.5) | 30 (2.1) | 6 (0.4) |
Female | 1095 | 1072 (97.9) | 15 (1.4) | 7 (0.6) |
Missing | 0 | 0 (0) | 0 (0) | 0 (0) |
Age group (years, n = 2462) | ||||
≥ 35 to < 50 | 707 | 694 (98.2) | 9 (1.3) | 4 (0.6) |
≥ 50 to < 65 | 1023 | 999 (97.7) | 20 (2.0) | 4 (0.4) |
≥ 65 to < 80 | 728 | 707 (97.1) | 15 (2.1) | 5 (0.7) |
Missing | 4 | 4 (100) | 0 (0) | 0 (0) |
Anthonisen grade | ||||
Type I | 1089 | 1065 (97.8) | 17 (1.6) | 7 (0.6) |
Type II | 1019 | 995 (97.6) | 21 (2.1) | 3 (0.3) |
Type III | 412 | 401 (97.3) | 7 (1.7) | 3 (0.7) |
Missing | 16 | 16 (100) | 0 (0) | 0 (0) |